Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-057852
Filing Date
2025-06-09
Accepted
2025-06-09 16:31:42
Documents
1
Period of Report
2025-06-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2517486-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2517486-1_4seq1.xml 4 7101
  Complete submission text file 0001104659-25-057852.txt   9880
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Reporting) CIK: 0001472322 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 251034571

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Mack Daniel (Reporting) CIK: 0001775831 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 251034569

Mailing Address C/O NANTAHALA CAPITAL MANAGEMENT, LLC 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address
Harkey Wilmot B. (Reporting) CIK: 0001775952 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 251034570